These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine. Veremis SA; Maddux MS; Pollak R; Kline SS; Mozes MF Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056 [TBL] [Abstract][Full Text] [Related]
9. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era. Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602 [No Abstract] [Full Text] [Related]
10. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation]. Hourmant M; Soulillou JP Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191 [TBL] [Abstract][Full Text] [Related]
11. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients. Benvenisty AI; Tannenbaum GA; Cohen DJ; Appel G; Hardy MA Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446 [No Abstract] [Full Text] [Related]